ABBV-744 clinical trial phase 2 data Things To Know Before You Buy
These side effects were notably milder compared to an inhibitor of both bromodomains. An in depth molecular analysis also discovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen TaylorGeneral, our existing work highlights the potential utilization of ARV-825 in combination with TAM. W